NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether James Hardie and certain of […]
NEW YORK, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ:LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. ("C3" or the "Company") (NYSE:AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE:SLQT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE:NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv-
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Flywire Corporation ("Flywire" or the "Company") (NASDAQ:FLYW) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-04110,
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fly-E Group, Inc. ("Fly-E" or the "Company") (NASDAQ:FLYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fly-E and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company")(NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ:PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the "Class Period"), of the important October 20,